[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371949-105":59,"doc-detail-371949-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","role-of-micrornas-in-hematological-malignancies-research-a-bibliometric-analysis","Role of microRNAs in hematological malignancies research - A bibliometric analysis","","MicroRNAs (miRNAs) act as pivotal regulators in cancer biology, including hematological malignancies, where they can suppress tumors, drive oncogenic processes, shape immune responses, and contribute to treatment resistance. This study quantitatively assessed publication trends from 2003 to 2024, thematic evolution, and key contributions. Methods combined BIBLIO-Checklist with VOSviewer and bibliometrix, using indices for author impact plus co-citation, co-authorship, and keyword co-occurrence networks.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-micrornas-in-hematological-malignancies-research-a-bibliometric-analysis/371949/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-micrornas-in-hematological-malignancies-research-a-bibliometric-analysis/371949.png","ImageObject",300,407,{"name":92,"@type":93},"RuangKosong","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the objective of the bibliometric study on miRNAs and hematological malignancies?","Question",{"text":112,"@type":113},"The study aimed to quantify research trends, thematic evolution, and major contributions in the field of microRNAs related to hematological malignancies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which tools and metrics were used to analyze the literature?",{"text":117,"@type":113},"BIBLIO-Checklist and visualization tools (VOSviewer and bibliometrix) were used. Author impact was assessed using indices such as the g-index, h-index, and m-index, along with co-citation, co-authorship, and keyword co-occurrence analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What major trend did the results show for miRNA research in hematological malignancies?",{"text":121,"@type":113},"The research output showed a robust upward trajectory, with an annual growth rate of 27.41%, and identified leading contributors including China, the USA, and Italy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371949,1790222344,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","®  \n Bibliometric Review   \nRole of microRNAs in hematological malignancies research  \nA bibliometric analysis  \nSaleh M. Abdullah, PhDa ,*  \n\n| Abstract\u003Cbr>Objectives: MicroRNAs (miRNAs) are pivotal regulators of cancer biology, including hematological malignancies. Their roles include tumor suppression, oncogenic activities, modulation of immune responses, and treatment resistance. This study aimed to provide a quantitative analysis of research trends, thematic evolution, and key contributions to the field of miRNAs and hematological malignancies.\u003Cbr>Methods: Using BIBLIO-Checklist and advanced visualization tools (VOSviewer and bibliometrix), data from key databases were analyzed for publication trends, author co-citations, thematic clusters, and emerging topics. Metrics such as the g-index, h-index, and m-index were used to assess author impact, while co-authorship networks and keyword co-occurrence patterns provided insights into collaboration and conceptual structure. This analysis was conducted from 2003 to 2024.\u003Cbr>Results: The analysis revealed a robust upward trajectory in the research output of miRNAs in hematological malignancies, with an annual growth rate of 27.41% . China, the USA, and Italy have emerged as leading contributors to the concentrated global interest. Core journals and prolific authors were identified, highlighting the influential works that shaped the field. Thematic evolution indicated an initial focus on foundational topics, such as acute myeloid leukemia and biomarkers, expanding to include chronic-lymphocytic leukemia, mesenchymal stem cells, and chemotherapy by 2017 to 2021. Recent research (2022–2024) emphasizes clinical applications, including drug resistance, immune infiltration, and targeted therapies. Co-citation analysis has identified key scholars, such as Calin and Anderson, leading to distinct thematic clusters. Investigation of the role of miRNAs in hematological malignancies has moved from initial identification to clinical translation, thus depicting increasing complexity and emphasis on personalized medicine.\u003Cbr>Conclusion: Certain patterns, especially the contributions of key academic authors, spatial aspects of their distribution, and changes in sub-disciplinary focus, speak for an active developing discipline with considerable scope for novel approaches to treatment, as well as enhanced clinical management of patients with malignant diseases of the blood.\u003Cbr>Abbreviations: AML = acute myeloid leukemia, BCL2 = B-cell lymphoma 2, CLL = chronic-lymphocytic leukemia, DLBCL = diffuse large B-cell lymphoma, MCP = multiple-country publications, miRNAs = microRNAs, SCP = single-country publications, TLS = total link strength. |\n| --- |\n| Keywords: hematological malignancies, microRNAs, thematic mapping, VOSviewer |\n\n1. Introduction  \nMicroRNAs (miRNAs) are important for gene expression regulation and their alterations have been found more frequently in the development and evolution of a variety of plasma disorders, including leukemias, lymphomas, and myelodysplastic syndromes. [1–3] miRNAs are short, non-coding RNA molecules with length of which is: 18 to 25 nucleotides and that bind to complementary sequences located in the 3′ untranslated region of target mRNA transcripts, resulting in either degradation of  \nthe mRNA molecule or inhibition of translation of the mRNA into protein. This regulatory mechanism is important for the control of normal hematopoiesis, and disturbances in miRNA expression contribute to hematopoietic imbalance, promoting the development of blood malignancies as well as a number of other hematological diseases. [4–6]  \nDuring normal hematopoiesis, miRNAs play a role in the differentiation, proliferation, and apoptosis of hematopoietic stem cells and their offspring. Certain miRNAs are required for  \nThe authors have no funding and conflicts of interest to disclose. The datasets generated during and/or analyzed during the current study are available from the corr","cbCaimUAnLx6H9Qz","https://ap.wps.com/l/cbCaimUAnLx6H9Qz","pdf",1270143,12,"English","# Abstract\n## Objectives\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the objective of the bibliometric study on miRNAs and hematological malignancies?\",\"answer\":\"The study aimed to quantify research trends, thematic evolution, and major contributions in the field of microRNAs related to hematological malignancies.\"},{\"question\":\"Which tools and metrics were used to analyze the literature?\",\"answer\":\"BIBLIO-Checklist and visualization tools (VOSviewer and bibliometrix) were used. Author impact was assessed using indices such as the g-index, h-index, and m-index, along with co-citation, co-authorship, and keyword co-occurrence analyses.\"},{\"question\":\"What major trend did the results show for miRNA research in hematological malignancies?\",\"answer\":\"The research output showed a robust upward trajectory, with an annual growth rate of 27.41%, and identified leading contributors including China, the USA, and Italy.\"}]","Role of microRNAs in hematological malignancies research - A bibliometric analysis | PDF",1790193305,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f559b32d5af8af7102371fe11bf7236.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a0e492bd34419c866ba4e935e80d36d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e1143fc3955abc8276223bb5a7f6d41.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41d0ae4154a0712022908ae52855bb3f.webp",980,1306]